News

MCG won AHA’s Innovation Award

 MCG won People’s Choice innovation award by popular audience vote at the AHA’s Philadelphia Heart Science Forum 2017.
More than 200 leaders in healthcare and technology joined together for the 2017 Heart Science Forum in Philadelphia to address the aims of the American Heart Association’s 2020 Impact Goal: to improve the cardiovascular health of all Americans by 20 percent while reducing death from cardiovascular diseases and stroke by 20 percent by the year 2020.
Competitors in the AHA Heart Innovation Forum Challenge (philadelphiaheartscienceforum.com) were evaluated on scientific and technical merit, innovativeness, readiness, the potential to scale to serve the U.S. population, and potential impact. Presented by Emergency MCG’s Dr. Leigh Mack, the Multifunction Cardiogram won the Forum’s People’s Choice innovation award by popular audience vote.

For details about AHA Heart Innovation Forum Challenge 2017, please click here

MCG study was presented at the 20th TCTAP in Korea

At the 20th TCTAP (Transcatheter Cardiovascular Therapeutics Asia Pacific Summit),MCG study was adapted and presented in May,2015, at Seoul, Korea.

TCTAP is an medical conference in the Asian region where the latest basic and clinical research related to blood vessels and structural heart disease, as well as the latest interventional techniques are presented, discussed and reviewed.

The study was conducted by  Kakogawa Shimin Hospital,  and its title is “Comparison of a Two-Lead,Computerized, Resting ECG Signal Analysis Device,the Multifunction-CardioGram（MCG）,to Coronary Angiography or MDCT, SPECT for the Detection of Relevant Coronary Artery Stenosis”

In this study, 95 patients were screened and the accuracy is 78.9%.It is concluded tat noninvasive MCG was very useful for screening.